1. Febuxostat improves outcome in a rat model of cancer cachexia. Issue 2 (21st April 2015) Authors: Konishi, Masaaki; Pelgrim, Loes; Tschirner, Anika; Baumgarten, Anna; von Haehling, Stephan; Palus, Sandra; Doehner, Wolfram; Anker, Stefan D.; Springer, Jochen Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 6:Issue 2(2015) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Formoterol in the treatment of experimental cancer cachexia: effects on heart function. Issue 4 (29th August 2014) Authors: Toledo, Míriam; Springer, Jochen; Busquets, Sílvia; Tschirner, Anika; López-Soriano, Francisco J.; Anker, Stefan D.; Argilés, Josep M. Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 5:Issue 4(2014) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Influence of cancer cachexia on drug liver metabolism and renal elimination in rats. Issue 1 (March 2015) Authors: Cvan Trobec, Katja; Kerec Kos, Mojca; Trontelj, Jurij; Grabnar, Iztok; Tschirner, Anika; Palus, Sandra; Anker, Stefan D.; Springer, Jochen; Lainscak, Mitja Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 6:Issue 1(2015) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Megestrol acetate improves cardiac function in a model of cancer cachexia‐induced cardiomyopathy by autophagic modulation. Issue 5 (7th April 2016) Authors: Musolino, Vincenzo; Palus, Sandra; Tschirner, Anika; Drescher, Cathleen; Gliozzi, Micaela; Carresi, Cristina; Vitale, Cristiana; Muscoli, Carolina; Doehner, Wolfram; von Haehling, Stephan; Anker, Stefan D.; Mollace, Vincenzo; Springer, Jochen Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 7:Issue 5(2016) Page Start: 555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia. Issue 2 (17th February 2020) Authors: Pötsch, Mareike S.; Ishida, Junichi; Palus, Sandra; Tschirner, Anika; von Haehling, Stephan; Doehner, Wolfram; Anker, Stefan D.; Springer, Jochen Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 11:Issue 2(2020) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Six1 is down‐regulated in end‐stage human dilated cardiomyopathy independently of Ezh2. (22nd January 2015) Authors: Tschirner, Anika; Palus, Sandra; Hetzer, Roland; Meyer, Rudolf; Anker, Stefan D.; Springer, Jochen Journal: ESC heart failure Issue: Volume 1:Number 2(2014:Dec.) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. Issue 2 (22nd November 2013) Authors: Pötsch, Mareike S.; Tschirner, Anika; Palus, Sandra; von Haehling, Stephan; Doehner, Wolfram; Beadle, John; Coats, Andrew J. S.; Anker, Stefan D.; Springer, Jochen Journal: Journal of cachexia, sarcopenia and muscle Issue: Volume 5:Issue 2(2014) Page Start: 149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗